{
    "clinical_study": {
        "@rank": "99351", 
        "brief_summary": {
            "textblock": "To assess the safety of intravenous itraconazole compared to amphotericin B in HIV positive\n      or negative persons with blastomycosis or histoplasmosis."
        }, 
        "brief_title": "A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis", 
        "condition": [
            "HIV Infections", 
            "Histoplasmosis", 
            "Blastomycosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Blastomycosis", 
                "Histoplasmosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients are randomized to receive IV itraconazole for 2 days, then either itraconazole\n      daily for 5 days or amphotericin B daily for 7 days. IV treatment is followed by\n      consolidation with oral itraconazole for up to 1 year."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV positive or negative status.\n\n          -  Blastomycosis or histoplasmosis.\n\n          -  Life expectancy of at least 1 week.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Liver disease.\n\n          -  Self-limiting fungal disease.\n\n          -  Very severe fungal disease such as meningeal involvement.\n\n          -  Acute respiratory disease.\n\n        Concurrent Medication:\n\n        Excluded at any time:\n\n          -  Terfenadine.\n\n          -  Astemizole.\n\n          -  Oral midazolam.\n\n          -  Triazolam.\n\n          -  Cisapride.\n\n          -  Phenytoin.\n\n          -  Phenobarbital.\n\n          -  Rifampin.\n\n          -  Rifabutin.\n\n        Excluded during oral consolidation:\n\n          -  H2 blockers.\n\n          -  Chronic antacids.\n\n          -  Omeprazole.\n\n          -  Lansoprazole.\n\n        Patients with the following prior condition are excluded:\n\n        Hypersensitivity to azole antifungals.\n\n        Prior Medication:\n\n        Excluded at any time:\n\n        More than 3 days of amphotericin B, fluconazole, or ketoconazole.\n\n        Excluded within 2 weeks prior to study entry:\n\n          -  Phenytoin.\n\n          -  Phenobarbital.\n\n          -  Rifampin.\n\n          -  Rifabutin."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": "60", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002159", 
            "org_study_id": "254A", 
            "secondary_id": "ITR-USA-118"
        }, 
        "intervention": [
            {
                "intervention_name": "Itraconazole", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Amphotericin B", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amphotericin B", 
                "Liposomal amphotericin B", 
                "Antifungal Agents", 
                "Itraconazole", 
                "Hydroxyitraconazole"
            ]
        }, 
        "keyword": [
            "Itraconazole", 
            "Histoplasmosis", 
            "Antifungal Agents", 
            "Acquired Immunodeficiency Syndrome", 
            "Amphotericin B", 
            "AIDS-Related Complex", 
            "Blastomycosis", 
            "Antibiotics, Antifungal"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "UAB Station / Infectious Division"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arkansas", 
                        "zip": "72205"
                    }, 
                    "name": "Univ of Arkansas for Med Sciences"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30303"
                    }, 
                    "name": "Division of Infectious Diseases"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Division of Inf Diseases/ Indiana Univ Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46218"
                    }, 
                    "name": "Community Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shreveport", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "71130"
                    }, 
                    "name": "LSU Med Ctr / Div of Pulmonary & Critical Care Med"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48105"
                    }, 
                    "name": "Ann Arbor Veterans Administration Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64132"
                    }, 
                    "name": "Infectious Diseases Association / Research Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "641082792"
                    }, 
                    "name": "Univ of Missouri / Division of Infectious Diseases"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002159"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Janssen, LP", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 1997"
    }, 
    "geocoordinates": {
        "Ann Arbor Veterans Administration Med Ctr": "42.281 -83.743", 
        "Community Hosp": "39.769 -86.158", 
        "Division of Inf Diseases/ Indiana Univ Hosp": "39.769 -86.158", 
        "Division of Infectious Diseases": "33.749 -84.388", 
        "Infectious Diseases Association / Research Med Ctr": "39.1 -94.579", 
        "LSU Med Ctr / Div of Pulmonary & Critical Care Med": "32.525 -93.75", 
        "UAB Station / Infectious Division": "33.521 -86.802", 
        "Univ of Arkansas for Med Sciences": "34.746 -92.29", 
        "Univ of Missouri / Division of Infectious Diseases": "39.1 -94.579"
    }
}